Peter Flynn
18Patents
6h-index
19Co-inventors
63Inventor score
Filing activity: May 7, 1999 → May 9, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7981843B2 | Antibody specificity transfer using minimal essential binding determinants | Chemistry; Metallurgy | 25 | Expired |
| US7964705B2 | Humaneered anti-factor B antibody | Chemistry; Metallurgy | 15 | Active |
| US10023879B2 | Minimal volume reprogramming of mononuclear cells | Chemistry; Metallurgy | 11 | Active |
| US6486672B1 | High-resolution NMR spectroscopy of molecules encapsulated in low-viscosity fluids | Emerging Cross-Sectional Technologies | 11 | Expired |
| US6198281A | NMR spectroscopy of large proteins | Emerging Cross-Sectional Technologies | 10 | Expired |
| US10954529B2 | Minimal volume reprogramming of mononuclear cells | Chemistry; Metallurgy | 7 | Active |
| US10844356B2 | Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs | Chemistry; Metallurgy | 5 | Active |
| US9732319B2 | Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs | Chemistry; Metallurgy | 5 | Active |
| US11268069B2 | Reprogramming methods and cell culture platforms | Chemistry; Metallurgy | 3 | Active |
| US9403885B2 | Wnt compositions and therapeutic uses of such compositions | Chemistry; Metallurgy | 1 | Active |
| US10273311B2 | Compositions to regulate renalase in the treatment of diseases and disorders | Physics | 1 | Active |
| US12264322B2 | Minimal volume reprogramming of mononuclear cells | Chemistry; Metallurgy | 0 | Active |
| US11370846B2 | Compositions and methods to regulate Renalase in the treatment of cancer | Physics | 0 | Active |
| US9096677B2 | Humaneered anti-factor B antibody | Chemistry; Metallurgy | 0 | Active |
| US9873722B2 | Wnt compositions and therapeutic uses of such compositions | Chemistry; Metallurgy | 0 | Active |
| US12415989B2 | Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs | Chemistry; Metallurgy | 0 | Active |
| US12152085B2 | Compositions and methods to regulate Renalase in the treatment of cancer | Physics | 0 | Active |
| US10618975B2 | Antibody to Renalase | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.